Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A bankerBig Pharma will increase acquisitions in 2025 due to patent expirations of major drugs.
How techbio is shaking up pharmaTech disruptors aim to revolutionize drug discovery in the pharma sector using AI to improve efficiency and understanding of biology.
Machine Learning for Biotech, Biopharma, and ML Safety Sessions Coming to ODSC East 2024Machine learning is crucial in safety, security, biotech, and pharma industries at ODSC East 2024.